secwatch / observer
8-K filed March 13, 2026, 7:59 PM ET ticker ADTX CIK 0001726711
M&A confidence high sentiment positive materiality 0.80

Aditxt, Inc. (ADTX): M&A transaction — Aditxt acquires Ignite Proteomics for $36M in preferred stock; issues $3.2M notes

Aditxt, Inc.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.95

Aditxt, Inc. incurred loan of aggregate principal amount of $3,194,444.44 with several buyers listed on the issuance schedule attached thereto at 6% per annum maturing nine months from the issuance date.

Instrument
loan
Principal
aggregate principal amount of $3,194,444.44
Counterparty
several buyers listed on the issuance schedule attached thereto
Rate
6% per annum
Maturity
nine months from the issuance date
Event
incurrence
Exact text from the filing
On March 11, 2026, the Company entered into a Note Purchase Agreement (the “Note Purchase Agreement”) with the several buyers listed on the issuance schedule attached thereto (the “Note Buyers”), pursuant to which the Company will issue its 10% original issue discount promissory notes (the “Notes”) for the aggregate principal amount of $3,194,444.44.
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Aditxt, Inc.: Filed Certificate of Designations creating Series A-2 Convertible Preferred Stock (effective 2026-03-10).

Change
charter amendment
Effective
2026-03-10
Exact text from the filing
On March 10, 2026, the Company filed the Certificate of Designations with the Delaware Secretary of State designating, 36,000 shares of its authorized and unissued Preferred Shares as Series A-2 Convertible Preferred Shares (the “Preferred Shares”).
View on SEC.gov
M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Aditxt, Inc. completed an acquisition involving IMAC Holdings, Inc. for 36,000 shares of the Company’s newly created Series A-2 Convertible Preferred Stock (closed 2026-03-11).

Action
acquisition
Counterparty
IMAC Holdings, Inc.
Consideration
36,000 shares of the Company’s newly created Series A-2 Convertible Preferred Stock
Closing
2026-03-11
Exact text from the filing
Agreement ”) with IMAC Holdings, Inc. (“ IMAC ”) and the several investors listed on the Schedule of Buyers attached to the Agreement (collectively, the “Buyers”)
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Aditxt, Inc. entered into Securities Purchase Agreement with IMAC Holdings, Inc. valued at 36,000 shares of Series A-2 Convertible Preferred Stock ($36,000,000 total stated value) for 100% eq (effective 2026-03-11).

Action
entry
Agreement
equity purchase
Counterparty
IMAC Holdings, Inc.
Value
36,000 shares of Series A-2 Convertible Preferred Stock ($36,000,000 total stated value) for 100% eq
Effective
2026-03-11
Exact text from the filing
On March 11, 2026, Aditxt, Inc. (the " Company ") entered into a Securities Purchase Agreement (the " Agreement ") with IMAC Holdings, Inc. (" IMAC ") and the several investors listed on the Schedule of Buyers attached to the Agreement (collectively, the "Buyers") whereby the Buyers sold 100% of their equity interests in Ignite Proteomics, LLC, a Delaware limited liability company (" Ignite ") and formerly a wholly owned subsidiary of IMAC plus $475,000 in cash, for a total consideration of 36,000 shares of the Company's newly created Series A-2 Convertible Preferred Stock (the " Preferred Shares ").
View on SEC.gov

103 debt financings filed in the last 30 days. Browse all debt financings →

Aditxt, Inc. filing history →

Source: SEC EDGAR
accession 0001213900-26-027281
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.